重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2015年
23期
3231-3232,3235
,共3页
覃川%杨秀江%晏怡%李柏成%邓伟%胡建刚%牛文勇%杨彪
覃川%楊秀江%晏怡%李柏成%鄧偉%鬍建剛%牛文勇%楊彪
담천%양수강%안이%리백성%산위%호건강%우문용%양표
卒中%睡眠障碍%心理疗法%随机对照试验
卒中%睡眠障礙%心理療法%隨機對照試驗
졸중%수면장애%심리요법%수궤대조시험
stroke%sleep disorders%psychotherapy%randomized controlled trial
目的:观察药物治疗联合心理治疗对脑卒中后睡眠障碍患者的临床疗效。方法选择符合条件的180例睡眠障碍患者,分为对照组和治疗组两组。对照组进行常规血管药物治疗,舒乐安定片2 mg,睡前服;治疗组在对照组治疗的基础上给予抗焦虑及镇静催眠药(文拉法辛、右佐匹克隆);治疗14 d 后组内、两组间比较治疗前后睡眠质量、神经功能缺损程度等。结果两组间及治疗组治疗前后患者 Barthel 指数、NIHSS 及 PSQI 比较,差异有统计学意义(P <0.05)。结论在常规脑血管药物基础上结合文拉法辛、右佐匹克隆及心理治疗能显著改善脑卒中患者的睡眠质量。
目的:觀察藥物治療聯閤心理治療對腦卒中後睡眠障礙患者的臨床療效。方法選擇符閤條件的180例睡眠障礙患者,分為對照組和治療組兩組。對照組進行常規血管藥物治療,舒樂安定片2 mg,睡前服;治療組在對照組治療的基礎上給予抗焦慮及鎮靜催眠藥(文拉法辛、右佐匹剋隆);治療14 d 後組內、兩組間比較治療前後睡眠質量、神經功能缺損程度等。結果兩組間及治療組治療前後患者 Barthel 指數、NIHSS 及 PSQI 比較,差異有統計學意義(P <0.05)。結論在常規腦血管藥物基礎上結閤文拉法辛、右佐匹剋隆及心理治療能顯著改善腦卒中患者的睡眠質量。
목적:관찰약물치료연합심리치료대뇌졸중후수면장애환자적림상료효。방법선택부합조건적180례수면장애환자,분위대조조화치료조량조。대조조진행상규혈관약물치료,서악안정편2 mg,수전복;치료조재대조조치료적기출상급여항초필급진정최면약(문랍법신、우좌필극륭);치료14 d 후조내、량조간비교치료전후수면질량、신경공능결손정도등。결과량조간급치료조치료전후환자 Barthel 지수、NIHSS 급 PSQI 비교,차이유통계학의의(P <0.05)。결론재상규뇌혈관약물기출상결합문랍법신、우좌필극륭급심리치료능현저개선뇌졸중환자적수면질량。
Objective To observe the clinical curative effect of drug combined with psychological treatment on patients with sleep disorders after stroke.Methods A total of 180 cases of eligible patients with sleep disorders were included and randomly di-vided into control group and treatment group.Control group were treated with conventional vascular drug(estazolam,2 mg,before sleep);treatment group increased anxiolytic and sedative hypnotic drugs(venlafaxine,dexzopiclone)compared to control group.Af-ter 14 days,sleep quality,NIHSS were compared both within the treatment group and between the two groups.Results The Bar-thel index,NIHSS and PSQI of two groups had significant differences,and those index of treatment group before and after treat-ment had significant differences too(P <0.05).Conclusion Combined conventional cerebrovascular drugs with Venlafaxine,dexzo-piclone as well as psychological treatment significantly improved sleep quality of patients with acute stroke.